245 related articles for article (PubMed ID: 33057023)
1. Immunodominant proteins P1 and P40/P90 from human pathogen Mycoplasma pneumoniae.
Vizarraga D; Kawamoto A; Matsumoto U; Illanes R; Pérez-Luque R; Martín J; Mazzolini R; Bierge P; Pich OQ; Espasa M; Sanfeliu I; Esperalba J; Fernández-Huerta M; Scheffer MP; Pinyol J; Frangakis AS; Lluch-Senar M; Mori S; Shibayama K; Kenri T; Kato T; Namba K; Fita I; Miyata M; Aparicio D
Nat Commun; 2020 Oct; 11(1):5188. PubMed ID: 33057023
[TBL] [Abstract][Full Text] [Related]
2. Detection of antibodies to Mycoplasma pneumoniae adhesion P1 in serum specimens from infected and non-infected subjects by immunoblotting.
Rastawicki W; Räty R; Kleemola M
Diagn Microbiol Infect Dis; 1996; 26(3-4):141-3. PubMed ID: 9078450
[TBL] [Abstract][Full Text] [Related]
3. Expression and immunological characterization of the carboxy-terminal region of the P1 adhesin protein of Mycoplasma pneumoniae.
Chaudhry R; Nisar N; Hora B; Chirasani SR; Malhotra P
J Clin Microbiol; 2005 Jan; 43(1):321-5. PubMed ID: 15634989
[TBL] [Abstract][Full Text] [Related]
4. Adhesion and inhibition assay of Mycoplasma genitalium and M. pneumoniae by immunofluorescence microscopy.
Svenstrup HF; Nielsen PK; Drasbek M; Birkelund S; Christiansen G
J Med Microbiol; 2002 May; 51(5):361-373. PubMed ID: 11990488
[TBL] [Abstract][Full Text] [Related]
5. [Use of recombinant P1 protein of Mycoplasma pneumoniae for the serodiagnosis of mycoplasmosis].
Rastawicki W; Rokosz N; Gierczyński R; Jagielski M
Med Dosw Mikrobiol; 2012; 64(3):229-37. PubMed ID: 23285777
[TBL] [Abstract][Full Text] [Related]
6. Delineation of immunodominant and cytadherence segment(s) of Mycoplasma pneumoniae P1 gene.
Chourasia BK; Chaudhry R; Malhotra P
BMC Microbiol; 2014 Apr; 14():108. PubMed ID: 24774062
[TBL] [Abstract][Full Text] [Related]
7. Attachment organelle formation represented by localization of cytadherence proteins and formation of the electron-dense core in wild-type and mutant strains of Mycoplasma pneumoniae.
Seto S; Miyata M
J Bacteriol; 2003 Feb; 185(3):1082-91. PubMed ID: 12533484
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of P1 adhesin, a leg protein of the gliding bacterium Mycoplasma pneumoniae.
Nakane D; Adan-Kubo J; Kenri T; Miyata M
J Bacteriol; 2011 Feb; 193(3):715-22. PubMed ID: 21097617
[TBL] [Abstract][Full Text] [Related]
9. Immune response to Mycoplasma pneumoniae P1 and P116 in patients with atypical pneumonia analyzed by ELISA.
Drasbek M; Nielsen PK; Persson K; Birkelund S; Christiansen G
BMC Microbiol; 2004 Feb; 4():7. PubMed ID: 15018643
[TBL] [Abstract][Full Text] [Related]
10. Molecular mimicry by Mycoplasma pneumoniae to evade the induction of adherence inhibiting antibodies.
Jacobs E; Bartl A; Oberle K; Schiltz E
J Med Microbiol; 1995 Dec; 43(6):422-9. PubMed ID: 7473675
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of P1 adhesin epitopes for the serodiagnosis of Mycoplasma pneumoniae infections.
Xue G; Cao L; Wang L; Zhao H; Feng Y; Ma L; Sun H
FEMS Microbiol Lett; 2013 Mar; 340(2):86-92. PubMed ID: 23227897
[TBL] [Abstract][Full Text] [Related]
12. Development of protective anti-Mycoplasma pneumoniae antibodies after immunization of guinea pigs with the combination of a P1-P30 chimeric recombinant protein and chitosan.
Hausner M; Schamberger A; Naumann W; Jacobs E; Dumke R
Microb Pathog; 2013 Nov; 64():23-32. PubMed ID: 23948467
[TBL] [Abstract][Full Text] [Related]
13. Antibody response to GroEL varies in patients with acute Mycoplasma pneumoniae infection.
Bencina D; Slavec B; Narat M
FEMS Immunol Med Microbiol; 2005 Mar; 43(3):399-406. PubMed ID: 15708314
[TBL] [Abstract][Full Text] [Related]
14. Visualization of the attachment organelle and cytadherence proteins of Mycoplasma pneumoniae by immunofluorescence microscopy.
Seto S; Layh-Schmitt G; Kenri T; Miyata M
J Bacteriol; 2001 Mar; 183(5):1621-30. PubMed ID: 11160093
[TBL] [Abstract][Full Text] [Related]
15. Cell surface processing of the P1 adhesin of Mycoplasma pneumoniae identifies novel domains that bind host molecules.
Widjaja M; Berry IJ; Jarocki VM; Padula MP; Dumke R; Djordjevic SP
Sci Rep; 2020 Apr; 10(1):6384. PubMed ID: 32286369
[TBL] [Abstract][Full Text] [Related]
16. Distinct Mycoplasma pneumoniae Interactions with Sulfated and Sialylated Receptors.
Williams CR; Chen L; Sheppard ES; Chopra P; Locklin J; Boons GJ; Krause DC
Infect Immun; 2020 Oct; 88(11):. PubMed ID: 32839185
[No Abstract] [Full Text] [Related]
17. Cloning, expression, and immunological characterization of the P30 protein of Mycoplasma pneumoniae.
Varshney AK; Chaudhry R; Kabra SK; Malhotra P
Clin Vaccine Immunol; 2008 Feb; 15(2):215-20. PubMed ID: 18032594
[TBL] [Abstract][Full Text] [Related]
18. Strategy to create chimeric proteins derived from functional adhesin regions of Mycoplasma pneumoniae for vaccine development.
Schurwanz N; Jacobs E; Dumke R
Infect Immun; 2009 Nov; 77(11):5007-15. PubMed ID: 19667041
[TBL] [Abstract][Full Text] [Related]
19. Mycoplasma pneumoniae infection and its genotypical characterization in children of Hokkaido, Japan.
Numazaki K; Umetsu M; Adachi N
In Vivo; 2003; 17(5):421-4. PubMed ID: 14598604
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological study of Mycoplasma pneumoniae infections in japan based on PCR-restriction fragment length polymorphism of the P1 cytadhesin gene.
Sasaki T; Kenri T; Okazaki N; Iseki M; Yamashita R; Shintani M; Sasaki Y; Yayoshi M
J Clin Microbiol; 1996 Feb; 34(2):447-9. PubMed ID: 8789036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
